trial · primary record
BON-106
Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 96 |
| Primary completion | 2030-12 |
| Primary endpoint | Dose Escalation Phase: Number of Participants with Dose-limiting Toxicities (DLTs) |
| Registry ID | NCT07893535 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:52.886Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07893535
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.